Casaccia, P. and Zhu, Y. and Cekanaviciute, E. and Debelius, J. and Bencosme, Y. and Mazmanian, S. and Knight, R. and Kanner, R. and Singh, S. and Cree, B. and Baranzini, S. and Katz-Sand, I. (2016) Effect of oral versus injectable disease-modifying therapies on the epigenome-wide DNA methylation and gut microbiota in multiple sclerosis patients. Multiple Sclerosis Journal, 22 (S3). p. 598. ISSN 1352-4585. https://resolver.caltech.edu/CaltechAUTHORS:20170324-104431759
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20170324-104431759
Abstract
[no abstract]
| Item Type: | Article | ||||||
|---|---|---|---|---|---|---|---|
| Related URLs: |
| ||||||
| ORCID: |
| ||||||
| Additional Information: | © 2016 SAGE Publications. | ||||||
| Issue or Number: | S3 | ||||||
| Record Number: | CaltechAUTHORS:20170324-104431759 | ||||||
| Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20170324-104431759 | ||||||
| Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||
| ID Code: | 75388 | ||||||
| Collection: | CaltechAUTHORS | ||||||
| Deposited By: | Tony Diaz | ||||||
| Deposited On: | 24 Mar 2017 18:53 | ||||||
| Last Modified: | 03 Oct 2019 16:49 |
Repository Staff Only: item control page
